[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  TheUrbanFarmer [@NattaCop](/creator/twitter/NattaCop) on x 1127 followers Created: 2025-07-02 07:34:32 UTC $ocgn Inside the new spending bill is something called the “Orphan Cures Act” and it changes everything. Ocugen’s modifier corrects XXX mutations. These mutations don’t just cause RP/LCA, those are just the two biggest markets. In reality, there are over XXX inherited retinal diseases in the U.S. with 5,000+ patients tied to those mutations that Ocugen’s modifier platform could treat in the same exact way. Altogether, it could potentially address 200+ inherited “retinal” diseases. Before this bill, government policy actually punished companies for expanding into more than one rare disease. Doing so triggered Medicare price negotiations and wrecked pricing power. After this bill a company can expand its rare disease reach without losing its exemption. For a drug that could treat hundreds of rare diseases, each with orphan status and holds a $1.5M price tag, the value of this legislation is almost beyond comprehension. Yup, it’s gonna cost taxpayers billions. Money well spent, for once! 🍻  XXXXX engagements  **Related Topics** [$ocgn](/topic/$ocgn) [Post Link](https://x.com/NattaCop/status/1940313122272665851)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TheUrbanFarmer @NattaCop on x 1127 followers
Created: 2025-07-02 07:34:32 UTC
$ocgn Inside the new spending bill is something called the “Orphan Cures Act” and it changes everything.
Ocugen’s modifier corrects XXX mutations. These mutations don’t just cause RP/LCA, those are just the two biggest markets. In reality, there are over XXX inherited retinal diseases in the U.S. with 5,000+ patients tied to those mutations that Ocugen’s modifier platform could treat in the same exact way. Altogether, it could potentially address 200+ inherited “retinal” diseases.
Before this bill, government policy actually punished companies for expanding into more than one rare disease. Doing so triggered Medicare price negotiations and wrecked pricing power. After this bill a company can expand its rare disease reach without losing its exemption.
For a drug that could treat hundreds of rare diseases, each with orphan status and holds a $1.5M price tag, the value of this legislation is almost beyond comprehension.
Yup, it’s gonna cost taxpayers billions. Money well spent, for once! 🍻
XXXXX engagements
Related Topics $ocgn